Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

   
   

A novel method of treating and preventing viral infection is provided. In particular a method of blocking viral infection facilitated by a serine proteolytic (SP) activity is disclosed, which consists of administering to a subject suffering or about to suffer from viral infection a therapeutically effective amount of a compound having a serine protease inhibitory or serpin activity. Among compounds are .alpha..sub.1 -antitrypsin (AAT), peptide derivatives from the carboxyterminal end of AAT, and man-made, synthetic compounds mimicking the action of such compounds. The preferred viral infections include retroviral infection such as human immunodeficiency virus (HIV) infection.

 
Web www.patentalert.com

< Megakaryocytic protein tyrosine kinase I

< Regulatory/unfolding peptides of ezrin

> Antibodies to cytokine receptor common gamma chain like

> Compounds and methods for the modulation of CD154

~ 00158